{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T03:14:46Z","timestamp":1790997286841,"version":"4.1.0"},"reference-count":63,"publisher":"Public Library of Science (PLoS)","issue":"12","license":[{"start":{"date-parts":[[2016,12,2]],"date-time":"2016-12-02T00:00:00Z","timestamp":1480636800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosntds.org"],"crossmark-restriction":false},"short-container-title":["PLoS Negl Trop Dis"],"DOI":"10.1371\/journal.pntd.0005171","type":"journal-article","created":{"date-parts":[[2016,12,2]],"date-time":"2016-12-02T13:25:07Z","timestamp":1480685107000},"page":"e0005171","update-policy":"https:\/\/doi.org\/10.1371\/journal.pntd.corrections_policy","source":"Crossref","is-referenced-by-count":69,"title":["Different Mutations in a P-type ATPase Transporter in Leishmania Parasites are Associated with Cross-resistance to Two Leading Drugs by Distinct Mechanisms"],"prefix":"10.1371","volume":"10","author":[{"given":"Christopher","family":"Fernandez-Prada","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabel M.","family":"Vincent","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie-Christine","family":"Brotherton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mathew","family":"Roberts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ga\u00e9tan","family":"Roy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luis","family":"Rivas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe","family":"Leprohon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Terry K.","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"Ouellette","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2016,12,2]]},"reference":[{"key":"ref1","unstructured":"WHO. Working to overcome the global impact of neglected tropical diseases. First WHO report on neglected tropical diseases. 2010."},{"key":"ref2","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1093\/bmb\/lds031","article-title":"Management of trypanosomiasis and leishmaniasis","volume":"104","author":"MP Barrett","year":"2012","journal-title":"British medical bulletin"},{"issue":"1","key":"ref3","doi-asserted-by":"crossref","first-page":"4","DOI":"10.4103\/2229-5070.129142","article-title":"Drug resistance in leishmaniasis: Newer developments","volume":"4","author":"S Mohapatra","year":"2014","journal-title":"Tropical parasitology"},{"issue":"4\u20135","key":"ref4","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.drup.2004.07.002","article-title":"Leishmaniasis: drugs in the clinic, resistance and new developments","volume":"7","author":"M Ouellette","year":"2004","journal-title":"Drug resistance updates: reviews and commentaries in antimicrobial and anticancer chemotherapy"},{"issue":"2","key":"ref5","doi-asserted-by":"crossref","first-page":"e16","DOI":"10.1086\/595710","article-title":"Parasite susceptibility to amphotericin B in failures of treatment for visceral leishmaniasis in patients coinfected with HIV type 1 and Leishmania infantum","volume":"48","author":"L Lachaud","year":"2009","journal-title":"Clinical infectious diseases: an official publication of the Infectious Diseases Society of America"},{"issue":"8","key":"ref6","doi-asserted-by":"crossref","first-page":"3088","DOI":"10.1128\/JCM.00173-11","article-title":"Unusual case of resistance to amphotericin B in visceral leishmaniasis in a region in India where leishmaniasis is not endemic","volume":"49","author":"P Srivastava","year":"2011","journal-title":"Journal of clinical microbiology"},{"issue":"4","key":"ref7","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1086\/519690","article-title":"Phase 4 trial of miltefosine for the treatment of Indian visceral leishmaniasis","volume":"196","author":"SK Bhattacharya","year":"2007","journal-title":"The Journal of infectious diseases"},{"issue":"2","key":"ref8","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1517\/14656566.2015.973850","article-title":"An update on pharmacotherapy for leishmaniasis","volume":"16","author":"S Sundar","year":"2015","journal-title":"Expert opinion on pharmacotherapy"},{"key":"ref9","article-title":"Cos-Seq for high-throughput identification of drug target and resistance mechanisms in the protozoan parasite Leishmania","author":"E Gazanion","year":"2016","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"7","key":"ref10","doi-asserted-by":"crossref","first-page":"2409","DOI":"10.1128\/AAC.48.7.2409-2414.2004","article-title":"Cloning of S-adenosyl-L-methionine:C-24-Delta-sterol-methyltransferase (ERG6) from Leishmania donovani and characterization of mRNAs in wild-type and amphotericin B-Resistant promastigotes","volume":"48","author":"M Pourshafie","year":"2004","journal-title":"Antimicrobial agents and chemotherapy"},{"issue":"2","key":"ref11","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1128\/AAC.42.2.352","article-title":"Mechanism of amphotericin B resistance in Leishmania donovani promastigotes","volume":"42","author":"N Mbongo","year":"1998","journal-title":"Antimicrobial agents and chemotherapy"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1007\/978-1-4899-0179-8_33","article-title":"Ether lipid metabolism, GPI anchor biosynthesis, and signal transduction are putative targets for anti-leishmanial alkyl phospholipid analogues","volume":"416","author":"H Lux","year":"1996","journal-title":"Advances in experimental medicine and biology"},{"issue":"4","key":"ref13","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1128\/AAC.01123-06","article-title":"Miltefosine affects lipid metabolism in Leishmania donovani promastigotes","volume":"51","author":"M Rakotomanga","year":"2007","journal-title":"Antimicrobial agents and chemotherapy"},{"issue":"3","key":"ref14","doi-asserted-by":"crossref","first-page":"247","DOI":"10.2174\/138920009787846332","article-title":"Cellular transport and lipid interactions of miltefosine","volume":"10","author":"G Barratt","year":"2009","journal-title":"Current drug metabolism"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"726328","DOI":"10.1155\/2014\/726328","article-title":"Comparative analysis of the omics technologies used to study antimonial, amphotericin B, and pentamidine resistance in leishmania","volume":"2014","author":"G Kaur","year":"2014","journal-title":"Journal of parasitology research"},{"issue":"1\u20132","key":"ref16","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.drup.2006.04.001","article-title":"Mechanisms of experimental resistance of Leishmania to miltefosine: Implications for clinical use","volume":"9","author":"FJ Perez-Victoria","year":"2006","journal-title":"Drug resistance updates: reviews and commentaries in antimicrobial and anticancer chemotherapy"},{"issue":"33","key":"ref17","doi-asserted-by":"crossref","first-page":"23766","DOI":"10.1074\/jbc.M605214200","article-title":"Phospholipid translocation and miltefosine potency require both L. donovani miltefosine transporter and the new protein LdRos3 in Leishmania parasites","volume":"281","author":"FJ Perez-Victoria","year":"2006","journal-title":"The Journal of biological chemistry"},{"issue":"4","key":"ref18","doi-asserted-by":"crossref","first-page":"e0154101","DOI":"10.1371\/journal.pone.0154101","article-title":"Genomic and Molecular Characterization of Miltefosine Resistance in Leishmania infantum Strains with Either Natural or Acquired Resistance through Experimental Selection of Intracellular Amastigotes","volume":"11","author":"A Mondelaers","year":"2016","journal-title":"PloS one"},{"issue":"1","key":"ref19","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.ijpddr.2013.11.002","article-title":"Untargeted metabolomic analysis of miltefosine action in Leishmania infantum reveals changes to the internal lipid metabolism","volume":"4","author":"IM Vincent","year":"2014","journal-title":"International journal for parasitology Drugs and drug resistance"},{"issue":"7","key":"ref20","doi-asserted-by":"crossref","first-page":"2677","DOI":"10.1128\/AAC.49.7.2677-2686.2005","article-title":"Alteration of fatty acid and sterol metabolism in miltefosine-resistant Leishmania donovani promastigotes and consequences for drug-membrane interactions","volume":"49","author":"M Rakotomanga","year":"2005","journal-title":"Antimicrobial agents and chemotherapy"},{"issue":"6","key":"ref21","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1097\/QCO.0b013e32833fca9d","article-title":"Drug combinations for visceral leishmaniasis","volume":"23","author":"PL Olliaro","year":"2010","journal-title":"Current opinion in infectious diseases"},{"issue":"12","key":"ref22","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1016\/S1473-3099(05)70296-6","article-title":"Treatment options for visceral leishmaniasis: a systematic review of clinical studies done in India, 1980\u20132004","volume":"5","author":"PL Olliaro","year":"2005","journal-title":"The Lancet Infectious diseases"},{"issue":"2","key":"ref23","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.ijpddr.2014.05.002","article-title":"Quantitative proteomic analysis of amphotericin B resistance in Leishmania infantum","volume":"4","author":"MC Brotherton","year":"2014","journal-title":"International journal for parasitology Drugs and drug resistance"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"e201","DOI":"10.1038\/cddis.2011.83","article-title":"Tolerance to drug-induced cell death favours the acquisition of multidrug resistance in Leishmania","volume":"2","author":"W Moreira","year":"2011","journal-title":"Cell death & disease"},{"issue":"Database issue","key":"ref25","doi-asserted-by":"crossref","first-page":"D457","DOI":"10.1093\/nar\/gkp851","article-title":"TriTrypDB: a functional genomic resource for the Trypanosomatidae","volume":"38","author":"M Aslett","year":"2010","journal-title":"Nucleic acids research"},{"issue":"11","key":"ref26","doi-asserted-by":"crossref","first-page":"e2564","DOI":"10.1371\/journal.pntd.0002564","article-title":"Gene amplification and point mutations in pyrimidine metabolic genes in 5-fluorouracil resistant Leishmania infantum","volume":"7","author":"JF Ritt","year":"2013","journal-title":"PLoS neglected tropical diseases"},{"issue":"14","key":"ref27","doi-asserted-by":"crossref","first-page":"1754","DOI":"10.1093\/bioinformatics\/btp324","article-title":"Fast and accurate short read alignment with Burrows-Wheeler transform","volume":"25","author":"H Li","year":"2009","journal-title":"Bioinformatics"},{"issue":"9","key":"ref28","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1101\/gr.107524.110","article-title":"The Genome Analysis Toolkit: a MapReduce framework for analyzing next-generation DNA sequencing data","volume":"20","author":"A McKenna","year":"2010","journal-title":"Genome research"},{"issue":"5","key":"ref29","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1038\/ng.806","article-title":"A framework for variation discovery and genotyping using next-generation DNA sequencing data","volume":"43","author":"MA DePristo","year":"2011","journal-title":"Nature genetics"},{"issue":"1","key":"ref30","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1038\/nmeth.1276","article-title":"High-resolution mapping of copy-number alterations with massively parallel sequencing","volume":"6","author":"DY Chiang","year":"2009","journal-title":"Nature methods"},{"issue":"10","key":"ref31","doi-asserted-by":"crossref","first-page":"3601","DOI":"10.1002\/j.1460-2075.1992.tb05444.x","article-title":"A novel antifolate resistance gene on the amplified H circle of Leishmania","volume":"11","author":"B Papadopoulou","year":"1992","journal-title":"The EMBO journal"},{"issue":"24","key":"ref32","doi-asserted-by":"crossref","first-page":"6336","DOI":"10.1016\/j.bmcl.2008.10.089","article-title":"Synthesis of BODIPY-labeled alkylphosphocholines with leishmanicidal activity, as fluorescent analogues of miltefosine","volume":"18","author":"V Hornillos","year":"2008","journal-title":"Bioorganic & medicinal chemistry letters"},{"issue":"5","key":"ref33","doi-asserted-by":"crossref","first-page":"e1002695","DOI":"10.1371\/journal.ppat.1002695","article-title":"ATG5 is essential for ATG8-dependent autophagy and mitochondrial homeostasis in Leishmania major","volume":"8","author":"RA Williams","year":"2012","journal-title":"PLoS pathogens"},{"issue":"9","key":"ref34","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1017\/S0031182010000715","article-title":"Lipidomic analysis of bloodstream and procyclic form Trypanosoma brucei","volume":"137","author":"GS Richmond","year":"2010","journal-title":"Parasitology"},{"key":"ref35","first-page":"349","article-title":"Glycobiology: A Practical Approach","author":"MAJ Ferguson","year":"1993"},{"issue":"12","key":"ref36","doi-asserted-by":"crossref","first-page":"e51300","DOI":"10.1371\/journal.pone.0051300","article-title":"Functional analysis of Leishmania cyclopropane fatty acid synthetase","volume":"7","author":"SO Oyola","year":"2012","journal-title":"PloS one"},{"issue":"12","key":"ref37","doi-asserted-by":"crossref","first-page":"2143","DOI":"10.1101\/gr.123430.111","article-title":"Whole genome sequencing of multiple Leishmania donovani clinical isolates provides insights into population structure and mechanisms of drug resistance","volume":"21","author":"T Downing","year":"2011","journal-title":"Genome research"},{"issue":"2","key":"ref38","doi-asserted-by":"crossref","first-page":"e1512","DOI":"10.1371\/journal.pntd.0001512","article-title":"Multiple mutations in heterogeneous miltefosine-resistant Leishmania major population as determined by whole genome sequencing","volume":"6","author":"AC Coelho","year":"2012","journal-title":"PLoS neglected tropical diseases"},{"issue":"2","key":"ref39","doi-asserted-by":"crossref","first-page":"e0003476","DOI":"10.1371\/journal.pntd.0003476","article-title":"Intrachromosomal amplification, locus deletion and point mutation in the aquaglyceroporin AQP1 gene in antimony resistant Leishmania (Viannia) guyanensis","volume":"9","author":"R Monte-Neto","year":"2015","journal-title":"PLoS neglected tropical diseases"},{"issue":"9","key":"ref40","doi-asserted-by":"crossref","first-page":"3102","DOI":"10.1128\/AAC.00423-06","article-title":"Combination of suboptimal doses of inhibitors targeting different domains of LtrMDR1 efficiently overcomes resistance of Leishmania spp. to Miltefosine by inhibiting drug efflux","volume":"50","author":"JM Perez-Victoria","year":"2006","journal-title":"Antimicrobial agents and chemotherapy"},{"issue":"2","key":"ref41","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.molbiopara.2009.12.004","article-title":"Phospholipid and sphingolipid metabolism in Leishmania","volume":"170","author":"K Zhang","year":"2010","journal-title":"Molecular and biochemical parasitology"},{"issue":"3","key":"ref42","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1002\/jms.3327","article-title":"Multiple-stage linear ion-trap with high resolution mass spectrometry towards complete structural characterization of phosphatidylethanolamines containing cyclopropane fatty acyl chain in Leishmania infantum","volume":"49","author":"FF Hsu","year":"2014","journal-title":"Journal of mass spectrometry: JMS"},{"issue":"2","key":"ref43","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/0166-6851(84)90004-5","article-title":"Sterols of Leishmania species. Implications for biosynthesis","volume":"10","author":"LJ Goad","year":"1984","journal-title":"Molecular and biochemical parasitology"},{"issue":"10","key":"ref44","doi-asserted-by":"crossref","first-page":"e1004427","DOI":"10.1371\/journal.ppat.1004427","article-title":"Sterol biosynthesis is required for heat resistance but not extracellular survival in leishmania","volume":"10","author":"W Xu","year":"2014","journal-title":"PLoS pathogens"},{"issue":"2","key":"ref45","doi-asserted-by":"crossref","first-page":"159","DOI":"10.4103\/0974-777X.62886","article-title":"Liposomal amphotericin B and leishmaniasis: dose and response","volume":"2","author":"S Sundar","year":"2010","journal-title":"Journal of global infectious diseases"},{"issue":"12","key":"ref46","doi-asserted-by":"crossref","first-page":"e1974","DOI":"10.1371\/journal.pntd.0001974","article-title":"Leishmania donovani develops resistance to drug combinations","volume":"6","author":"R Garcia-Hernandez","year":"2012","journal-title":"PLoS neglected tropical diseases"},{"issue":"50","key":"ref47","doi-asserted-by":"crossref","first-page":"49965","DOI":"10.1074\/jbc.M308352200","article-title":"Functional cloning of the miltefosine transporter. A novel P-type phospholipid translocase from Leishmania involved in drug resistance","volume":"278","author":"FJ Perez-Victoria","year":"2003","journal-title":"The Journal of biological chemistry"},{"issue":"49","key":"ref48","doi-asserted-by":"crossref","first-page":"41139","DOI":"10.1074\/jbc.M112.413039","article-title":"Biochemical characterization of P4-ATPase mutations identified in patients with progressive familial intrahepatic cholestasis","volume":"287","author":"A Stone","year":"2012","journal-title":"The Journal of biological chemistry"},{"issue":"5","key":"ref49","doi-asserted-by":"crossref","first-page":"E358","DOI":"10.1073\/pnas.1216948110","article-title":"Two-gate mechanism for phospholipid selection and transport by type IV P-type ATPases","volume":"110","author":"RD Baldridge","year":"2013","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"6","key":"ref50","doi-asserted-by":"crossref","first-page":"E290","DOI":"10.1073\/pnas.1115725109","article-title":"Identification of residues defining phospholipid flippase substrate specificity of type IV P-type ATPases","volume":"109","author":"RD Baldridge","year":"2012","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"8","key":"ref51","doi-asserted-by":"crossref","first-page":"2190","DOI":"10.1128\/AAC.44.8.2190-2192.2000","article-title":"In vitro reversion of amphotericin B resistance in Leishmania donovani by poloxamer 188","volume":"44","author":"S Espuelas","year":"2000","journal-title":"Antimicrobial agents and chemotherapy"},{"issue":"7","key":"ref52","doi-asserted-by":"crossref","first-page":"e0003948","DOI":"10.1371\/journal.pntd.0003948","article-title":"Fitness and Phenotypic Characterization of Miltefosine-Resistant Leishmania major","volume":"9","author":"KG Turner","year":"2015","journal-title":"PLoS neglected tropical diseases"},{"issue":"7","key":"ref53","doi-asserted-by":"crossref","first-page":"e2999","DOI":"10.1371\/journal.pntd.0002999","article-title":"In vitro and in vivo miltefosine susceptibility of a Leishmania amazonensis isolate from a patient with diffuse cutaneous leishmaniasis","volume":"8","author":"AC Coelho","year":"2014","journal-title":"PLoS neglected tropical diseases"},{"issue":"2","key":"ref54","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1128\/AAC.00030-11","article-title":"Mechanism of amphotericin B resistance in clinical isolates of Leishmania donovani","volume":"56","author":"B Purkait","year":"2012","journal-title":"Antimicrobial agents and chemotherapy"},{"issue":"3","key":"ref55","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1007\/s00216-011-5520-3","article-title":"Identification of phospholipid species affected by miltefosine action in Leishmania donovani cultures using LC-ELSD, LC-ESI\/MS, and multivariate data analysis","volume":"402","author":"L Imbert","year":"2012","journal-title":"Analytical and bioanalytical chemistry"},{"issue":"8","key":"ref56","doi-asserted-by":"crossref","first-page":"e12443","DOI":"10.1371\/journal.pone.0012443","article-title":"Disruption of the lipid-transporting LdMT-LdRos3 complex in Leishmania donovani affects membrane lipid asymmetry but not host cell invasion","volume":"5","author":"A Weingartner","year":"2010","journal-title":"PloS one"},{"issue":"4","key":"ref57","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1128\/.61.4.429-441.1997","article-title":"Cyclopropane ring formation in membrane lipids of bacteria","volume":"61","author":"DW Grogan","year":"1997","journal-title":"Microbiology and molecular biology reviews: MMBR"},{"issue":"6","key":"ref58","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1016\/j.resmic.2008.04.011","article-title":"Cyclopropane fatty acids improve Escherichia coli survival in acidified minimal media by reducing membrane permeability to H+ and enhanced ability to extrude H+","volume":"159","author":"L Shabala","year":"2008","journal-title":"Research in microbiology"},{"issue":"3","key":"ref59","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1042\/bj0960771","article-title":"Some factors affecting cyclopropane acid formation in Escherichia coli","volume":"96","author":"VA Knivett","year":"1965","journal-title":"The Biochemical journal"},{"issue":"2","key":"ref60","doi-asserted-by":"crossref","first-page":"69","DOI":"10.4161\/gmic.2.2.15282","article-title":"Cyclopropane fatty acid synthase mutants of probiotic human-derived Lactobacillus reuteri are defective in TNF inhibition","volume":"2","author":"SE Jones","year":"2011","journal-title":"Gut microbes"},{"issue":"17","key":"ref61","doi-asserted-by":"crossref","first-page":"5487","DOI":"10.1021\/acs.jpcb.5b00958","article-title":"A ring to rule them all: the effect of cyclopropane Fatty acids on the fluidity of lipid bilayers","volume":"119","author":"D Poger","year":"2015","journal-title":"The journal of physical chemistry B"},{"issue":"8","key":"ref62","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1038\/sj.embor.7400208","article-title":"The complex life of simple sphingolipids","volume":"5","author":"AH Futerman","year":"2004","journal-title":"EMBO reports"},{"issue":"2","key":"ref63","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1128\/AAC.01233-08","article-title":"In vitro susceptibility of field isolates of Leishmania donovani to Miltefosine and amphotericin B: correlation with sodium antimony gluconate susceptibility and implications for treatment in areas of endemicity","volume":"53","author":"D Kumar","year":"2009","journal-title":"Antimicrobial agents and chemotherapy"}],"container-title":["PLOS Neglected Tropical Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pntd.0005171","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,27]],"date-time":"2020-09-27T14:17:06Z","timestamp":1601216226000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pntd.0005171"}},"subtitle":[],"editor":[{"given":"Louis","family":"Maes","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2016,12,2]]},"references-count":63,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2016,12,2]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pntd.0005171","relation":{},"ISSN":["1935-2735"],"issn-type":[{"value":"1935-2735","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,12,2]]}}}